Changes to global attitudes in the last decade has seen legalization, followed by huge market growth, of medicines employing previously prohibited substances - cannabis being the leading example.
Now, leading scientists, academic institutions and government administrations are turning their attention to the benefits of psilocybin as a potential treatment for the global problems of mental health and end of life care. The ability to produce this molecule quickly, economically and cleanly, as Pharmadelic Labs is aiming to achieve, will be in high demand when psilocybin gains widespread acceptance.